Critically, this design ensures that changes in putative mediators temporally precede the primary outcome (relapse / recurrence), a prerequisite in inferring mediation, and allows baseline - to -
post-treatment change in symptoms to be statistically controlled.
Not exact matches
In terms of neurophysiological
symptoms, mean scores of 0.43 pre-treatment and 0.34
post-treatment were not significantly different; however, subjective feelings of anxiety significantly
changed between pre-treatment, 1.05, and
post-treatment, 0.55.
Presence and severity of child primary anxiety disorder (Anxiety Disorders Interview Schedule for DSM - IV, child / parent versions), improvement
in child presentation of anxiety (Clinical Global Impression — Improvement scale), and
change in child anxiety
symptoms (Spence Children's Anxiety Scale, child / parent version and Child Anxiety Impact scale, parent version) were assessed at
post-treatment and for those
in the two active treatment groups, 6 months
post-treatment.